Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Multimorbidity, polypharmacy and regimen complexity: the example of people with cognitive and functional decline

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: BELL, Simon (Monash University, Centre for Medicine Use and Safety, Parkville, Australia)
  • Abstract:

    Polypharmacy and multimorbidity are common exclusion criteria in randomised controlled trials (RCTs). RCTs may be underpowered or not designed to assess a range of adverse events considered important to older people, including impaired cognition, hospitalisation and institutionalisation. Most RCTs have a drug-specific focus without considering an..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses